Dr. Wouter Hendrickx is the principal investigator of the Functional Cancer Omics Laboratory in the cancer department at Sidra Medicine. He has previous experience in stem cell and cancer research at the universities of Brussels, Leuven, and Norwich. He joined Sidra Medicine as a senior postdoctoral fellow and has headed his own lab since 2017. He has 40+ publications in peer-reviewed journals and has an h-index of 20.
Sidra Medicine, PI of the Functional Cancer Omics Lab, Doha, Qatar
Dec 2017 - PresentCancer Immunotherapy and immunogenetics, Doha, Qatar
Nov 2014 - Nov 2017University of East Anglia, Proteases in Breast and pancreatic cancer, Norwich, United Kingdom
Aug 2012 - Mar 2014University of East Anglia, Selenium and prostate cancer, Norwich, United Kingdom
Sep 2008 - Sep 2012Free University of Brussels (Belgium)
Catholic University of Leuven (Belgium)
University of East Anglia (UK)
“Oncogenic States Dictate the Prognostic and Predictive Connotations of Intratumoral Immune Response.” Journal for Immunotherapy of Cancer 8, no. 1 (May 5, 2020). https://doi.org/10.1136/jitc-2020-000617.
2020“Transcriptomic Profiles Conducive to Immune-Mediated Tumor Rejection in Human Breast Cancer Skin Metastases Treated with Imiquimod.” Scientific Reports 9, no. 1 (June 12, 2019): 8572. https://doi.org/10.1038/s41598-019-42784-9.
2019“Immunogenomic Classification of Colorectal Cancer and Therapeutic Implications.” International Journal of Molecular Sciences 18, no. 10 (October 24, 2017): 2229. https://doi.org/10.3390/ijms18102229.
2017“Identification of Genetic Determinants of Breast Cancer Immune Phenotypes by Integrative Genome-Scale Analysis.” OncoImmunology 0, no. ja (February 6, 2017): 00–00. https://doi.org/10.1080/2162402X.2016.1253654.
2017